HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation

Detalles Bibliográficos
Autores principales: Jin, Xin, Cao, Yaqing, Wang, Luqiao, Sun, Rui, Cheng, Lin, He, Xiaoyuan, Xiao, Xia, Jiang, Yili, Li, Qing, Zhang, Huan, Lu, Wenyi, Lyu, Cuicui, Jiang, Yanyu, Meng, Juanxia, Zhao, Mingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214243/
https://www.ncbi.nlm.nih.gov/pubmed/31628429
http://dx.doi.org/10.1038/s41375-019-0610-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214243/
https://www.ncbi.nlm.nih.gov/pubmed/31628429
http://dx.doi.org/10.1038/s41375-019-0610-x

Ejemplares similares